Sep 01, 2026
By Transpire Insight
Description
According to a research report published by Transpire Insight, the elastomeric infusion pumps market size is projected to grow from USD 1.8 billion in 2026 to USD 4.3 billion by 2035, at a CAGR of 4.5% during the forecast period 2026-2035. The growth of the market is largely driven by the increasing adoption of home healthcare, the rise in surgical procedures, and the rising prevalence of chronic diseases. Moreover, positive reimbursement policies under the NOPAIN Act and technological improvements in leak-resistant elastomeric membranes make for impressive clinical demand.
Introduction
The elastomeric infusion pumps market is growing rapidly as there is increasing preference for portability and non-electronic medication delivery systems. They are single-use balloon devices that deliver continuous or variable doses of critical drugs, such as chemotherapy, local anesthetics, or antibiotics. Elastomeric pumps remove the need for batteries and complicated programming, improve patient mobility, and decrease clinical errors in home and ambulatory situations. These modern infusion systems continue to be an essential tool in the field of pain management and chronic disease treatment, particularly as more focus is placed on outpatient treatment and cost-effective healing.
Recent Development News
Stay Ahead of Emerging Opportunities with Expert Market Insights by Transpire Insight
Transpire Insight provides comprehensive, data-driven market intelligence to support smarter business decisions. Our research is rooted in comprehensive analysis, authoritative predictions, and industry expertise, enabling organizations to make informed decisions in rapidly evolving markets. In-depth analysis of market segmentation, competitive positioning, regional trends, and emerging investment opportunities in high-growth areas. We blend accuracy with actionable intelligence, empowering companies to uncover new avenues for growth, bolster strategic decision-making, and stay ahead in a dynamic market.
Elastomeric Infusion Pumps Market Size & Statistics
Regional Growth and Demand Analysis by Transpire Insight
North America is expected to grow the fastest during the forecast period in the elastomeric infusion pumps market. The insurer-pharmacy network of Elevance Health, the firm behind the Paragon Healthcare infusion centres, expanded pump access in multiple states when it acquired the infusion centres. B. Braun has increased their disposable pump portfolio in the region, with SMARTeZ elastomeric pumps designed for intermittent and continuous antibiotic, chemotherapy, and general infusion therapy. The region continues to dominate sales based on revenue, as hospitals and home healthcare agencies spend at scale on the pumps, despite increasing sales growth in other regions, due to favorable FDA approval timelines, robust reimbursement coverage per treatment episode, and an increasing preference for home-based chemotherapy and pain management.
The elastomeric infusion pumps market in Asia Pacific is expected to witness the highest demand during the forecast period. China's Healthy China plan is expanding community-based care, and the idea of home infusions for chronic diseases such as hepatitis is growing in the country; meanwhile, Japan's aging population is driving the demand for quieter, dementia-friendly pump designs. India is reinforcing its hospital-at-home initiatives in tier-two cities with the folding of disposable elastomeric devices, while a regional device maker has been acquired by Baxter International, which has expanded its distribution network throughout Southeast Asia. Such factors as increasing disposable incomes, growing hospital networks, and manufacturers decentralizing production and regulatory dossiers are driving the region to outpace Europe and other markets in growth.
Top 15 Trends in the Elastomeric Infusion Pumps Market
Home-Based Chemotherapy Shift
Patients increasingly receive chemotherapy and antibiotic infusions at home rather than hospitals, cutting costs and freeing up clinical capacity while pump makers redesign devices for non-clinical caregiver use.
Smart, IoT-Enabled Pumps
Manufacturers are embedding remote-monitoring sensors into elastomeric pumps, letting clinicians track infusion progress and flag issues remotely, improving safety for patients managing therapy outside hospital settings.
Non-Opioid Pain Management
Reimbursement policies increasingly favor elastomeric pumps for post-surgical pain control over opioids, driving hospitals and ambulatory centers to adopt disposable infusion devices as a lower-risk alternative.
Provider and Insurer Consolidation
Insurers acquiring ambulatory infusion networks are bundling pump procurement with pharmacy and clinical services, widening patient access while concentrating purchasing power among fewer large healthcare organizations.
Eco-Friendly Materials
Rising sustainability pressure is pushing manufacturers toward recyclable or lower-impact balloon reservoir materials, addressing environmental concerns tied to single-use medical device waste in high-volume clinical settings.
Hospital-at-Home Expansion
Emerging-market health systems are folding disposable elastomeric pumps into hospital-at-home programs, extending infusion therapy access to tier-two cities and reducing pressure on overcrowded urban hospital facilities.
List of Top 25 Companies Leading the Elastomeric Infusion Pumps Market
1. Baxter International Inc.
Leading innovator providing versatile single-use elastomeric systems for home infusion therapies.
Founded: 1931 | HQ: Deerfield, Illinois, USA.
Why It Ranks: Unmatched distribution footprint combined with high-volume institutional procurement contracts worldwide.
Regional Dominance: Maintains top market share across North American and Western European healthcare facilities.
Product Line: Infusor and Fuser single-use ambulatory pumps delivering continuous intravenous treatments.
2. B. Braun Melsungen AG
Renowned medical technology giant manufacturing robust continuous and variable elastomeric delivery systems.
Founded: 1839 | HQ: Melsungen, Germany.
Why It Ranks: Dominates European hospital networks through superior quality assurance and regulatory leadership.
Regional Dominance: Holds commanding market position throughout Europe and expanding Asia-Pacific healthcare sectors.
Product Line: Easypump II disposable elastomeric infusion pumps designed for safe ambulatory therapy.
3. Avanos Medical, Inc.
Premier medical device developer specializing in advanced non-opioid surgical pain management solutions.
Founded: 2014 | HQ: Alpharetta, Georgia, USA.
Why It Ranks: Market leadership in postoperative pain control via localized surgical nerve block infusions.
Regional Dominance: Strongly leads the North American ambulatory surgical center and outpatient care segments.
Product Line: ON-Q Pain Relief System featuring customizable targeted elastomeric local anesthetic delivery.
4. Nipro Corporation
Major Japanese healthcare leader producing high-precision medical devices and elastomeric infusion pumps.
Founded: 1954 | HQ: Osaka, Japan.
Why It Ranks: Exceptional manufacturing scale paired with extensive penetration into Asian clinical supply chains.
Regional Dominance: Dominates the East Asian market while steadily expanding European distribution networks.
Product Line: Surefuser disposable elastomeric infusion systems engineered for reliable long-term drug administration.
5. Terumo Corporation
medical technology titan producing high-grade fluid management and infusion device solutions.
Founded: 1921 | HQ: Tokyo, Japan.
Why It Ranks: Deep clinical presence and pioneering elastomer engineering for stable flow control.
Regional Dominance: Holds substantial market dominance across Asia-Pacific and selective Latin American territories.
Product Line: Terufusion elastomeric pumps created for smooth, precise outpatient medication administration.
6. Vygon SA
Specialized French medical device manufacturer dedicated to critical care and surgical infusions.
Founded: 1962 | HQ: Écouen, France.
Why It Ranks: Trusted reputation for high-safety pediatric and adult continuous elastomeric infusion devices.
Regional Dominance: Strong clinical market presence across Western European and North African hospital networks.
Product Line: Accufuser elastomeric pump series designed for accurate chemotherapy and pain management.
7. Leventon, S.A.U.
Specialized Spanish manufacturer focusing exclusively on disposable flow control and infusion technologies.
Founded: 1979 | HQ: Barcelona, Spain.
Why It Ranks: Dedicated expertise in producing highly customizable elastomeric pumps for specialized treatments.
Regional Dominance: Captures significant market share across Southern Europe and Latin American clinical sectors.
Product Line: Dosi-Fuser elastomeric infusion pumps featuring integrated variable and continuous flow options.
8. Ambu A/S
Innovation-driven Danish medical enterprise developing disposable diagnostic and single-use delivery products.
Founded: 1937 | HQ: Ballerup, Denmark.
Why It Ranks: Strong focus on single-use safety standards that eliminate cross-contamination risks.
Regional Dominance: Establishes major presence throughout Northern Europe and North American outpatient settings.
Product Line: Single-use disposable elastomeric pumps tailored for continuous pain relief and chemotherapy.
9. Micrel Medical Devices S.A.
Pioneer in dynamic ambulatory infusion systems providing ergonomic patient-focused drug delivery technologies.
Founded: 1980 | HQ: Athens, Greece.
Why It Ranks: Specialized engineering capabilities producing lightweight pumps optimized for high patient mobility.
Regional Dominance: Operates robust distribution channels across Eastern and Western European regional markets.
Product Line: MP elastomeric series offering continuous flow accuracy for homecare and oncology.
10. Ace Medical Co., Ltd.
Prominent South Korean medical manufacturer leading regional advancements in ambulatory infusion pumps.
Founded: 1992 | HQ: Seoul, South Korea.
Why It Ranks: Broad market adoption in Asia driven by cost-effective, high-quality patient-controlled analgesia.
Regional Dominance: Leads domestic South Korean markets while aggressively expanding across Southeast Asia.
Product Line: AutoFuser elastomeric infusion pumps designed for patient-controlled and continuous pain management.
Conclusion
The elastomeric infusion pumps market is set to witness continued growth owing to the rising trend of shifting the healthcare delivery system to outpatient and homecare facilities. This is supported by key drivers like non-opioid reimbursement programs and the development of bio-based silicone membranes, which further ensure device accuracy and clinical safety. Major brands such as Baxter and B. Braun are continuing to build on their international presence with the development of specific products. In conclusion, elastomeric pumps continue to be essential in the medical field, providing reliable and convenient operation without the need for batteries or electricity, which is crucial for enhancing patient care and optimizing clinical practices in modern times.
Send us a brief description of your challenge and we'll get back to you within 24 hours.
inquiry@transpireinsight.com
APAC:+91 7666513636
Address
